Clinical Nurse Specialist in Grand Rapids, MI Accepting Medicare

24 Clinical Nurse Specialist nurses found. Showing 21 - 24

Geralyn Marie Lerg, MS RN CPTC Clinical Nurse Specialist - Transplantation Medicare: Not Enrolled in Medicare Practice Location: 330 Barclay Ave Ne Ste 200, Grand Rapids, MI 49503 Phone: 616-550-7766

Lisa J Grandon, LPN Clinical Nurse Specialist - Community Health/Public Health Medicare: Not Enrolled in Medicare Practice Location: 1215 Fulton St E, Grand Rapids, MI 49503 Phone: 616-742-0351    Fax: 616-742-0370

Dr. Kellie Joyce, ACCNS-P Clinical Nurse Specialist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-267-0107

Mrs. Melanie Sloffer, NP Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 4100 Lake Dr Se, Suite 205, Grand Rapids, MI 49546 Phone: 616-356-4100

News Archive

Essilor announces acquisition of 50% of Shamir Optical

Shamir Optical Industry Ltd., Kibbutz Shamir and Essilor International today announced that they have signed an agreement whereby Essilor will, through a series of transactions, acquire 50% of Shamir Optical. As a result of these transactions, Kibbutz Shamir and Essilor will each own 50% of Shamir Optical.

Abbott presents data from 4 briakinumab pivotal studies in psoriasis

In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (Enbrel®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Inviragen and PharmaJet announced the award of a five year, $15.5 million dollar contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to advance the development of a needle-free, easy to administer dengue vaccine. The award will fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen's tetravalent dengue vaccine, DENVax delivered with PharmaJet's convenient needle-free injection device.

Médecins Sans Frontières' concerns over TPP negotiations

As closed-door talks for the Trans-Pacific Partnership (TPP) Agreement resume in Singapore this week, international medical humanitarian organisation Médecins Sans Frontières is calling on Australia and negotiating countries to reject rules that threaten to dismantle internationally agreed public health safeguards and restrict access to medicines in developing countries.

Read more Medical News

› Verified 1 days ago

• 1
• 2(current)